Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111572) titled 'Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis' on Aug. 1.
Study Type: Observational
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Ulcerative Colitis (UC)
Fecal Calprotetin
FIT
Intervention:
Diagnostic Test: fecal calprotectin
Recruitment Status: Not recruiting
Date of First Enrollment: August 1, 2025
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111572
Published by HT Digital Content Services with permission from Health Daily Digest....